▼ SELL
10b5-1 Plan
$ Value
$22K
Shares
10,684
Price
$2
Filed
Aug 27
Insider
Name
Hemrajani Rekha
Title
—
CIK
0001771213
Roles
Director
Transaction Details
Transaction Date
2025-06-25
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
39,893
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2025. | The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.07 to $2.1212, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filing Info
Hemrajani Rekha's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-20 | ALXO | A | $0 |
| 2025-09-10 | LBRX | A | $0 |
| 2025-06-25 | MXCT | ▼ | $22K |
| 2025-06-18 | MXCT | A | $0 |
| 2025-06-18 | MXCT | A | $0 |
| 2025-06-05 | BIOA | A | $0 |
Other Insiders at MXCT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Masoud Maher
President and CEO
|
— | — | 2026-03-27 |
|
Ahuja Parmeet
Chief Financial Officer
|
— | — | 2026-04-15 |